4. Investing genetic variations associated with breast cancer using RNA sequencing data

Phan Huy Giang, Hoang Hong Tham, Vo Sy Nam, Nguyen Hoang Quan, Trinh Le Huy, Vu Minh Giang, Hoang Yen, Tran Huy Thinh

Main Article Content

Abstract

This study aims to investigate gene genetic variants associated with breast cancer using RNA sequencing (RNA-seq) data. We conducted a study with 5 breast cancer (BC) patients and 8 controls from 1000 Vietnamese genomes project (VN1K) data. Over 5 women with breast cancer and 8 healthy controls of similar age. We apply a cross-sectional method to understand germline variants present in breast cancer patients through RNA sequencing of blood samples. By analyzing the RNA-seq data, we identified 143 genes with significant expression differences between the BC group and the healthy controls. Next, we observed a total of 3515 variants located on such genes. Among them, 8 variants have been reported to probably increase BC risk, 2 variants were included in the dbSNP, rs35400274 and rs34406374. rs35400274 forms a premature termination triplet located on the C17orf107 gene, reducing gene expression levels in the BC group, Log2FoldChange = -2,49 and p-value = 0,002, this variant has also been reported to be present in colorectal cancer patients in the COSMIC database. Meanwhile, rs7937 is associated with breast cancer traits in the GWAS-Catalog database due to its influence on Letrozole drug concentrations. Results from this study provide additional insights into the pathogenesis and impact of genetic variants on breast cancer risk in women.

Article Details

References

1. Jenkins C, Ha DT, Lan VT, et al. Breast Cancer messaging in Vietnam: an online media content analysis. BMC Public Health. 2020; 20:966. doi:10.1186/s12889-020-09092-8.
2. Ellisen LW, Haber DA. Hereditary breast cancer. Annu Rev Med. 1998; 49: 425-436. doi:10.1146/annurev.med.49.1.425.
3. de Nóbrega M, Cilião HL, de Souza MF, et al. Association of polymorphisms of PTEN, AKT1, PI3K, AR, and AMACR genes in patients with prostate cancer. Genet Mol Biol. 2020; 43(3): e20180329. doi:10.1590/1678-4685-GMB-2018-0329.
4. Bakhtiarizadeh MR, Alamouti AA. RNA-Seq based genetic variant discovery provides new insights into controlling fat deposition in the tail of sheep. Sci Rep. 2020; 10(1): 13525. doi:10.1038/s41598-020-70527-8.
5. Le TNN, Tran VK, Nguyen TT, et al. BRCA1/2 Mutations in Vietnamese Patients with Hereditary Breast and Ovarian Cancer Syndrome. Genes. 2022; 13(2): 268. doi:10.3390/genes13020268.
6. Hertz DL, Douglas JA, Kidwell KM, et al. Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity. Pharmacogenet Genomics. 2021; 31(5): 116-123. doi:10.1097/FPC.0000000000000429.
7. GARCÍA PARRA-PÉREZ FA, ZAVALA-POMPA A, PACHECO-CALLEROS J, et al. Monosomy of chromosome 8 could be considered as a primary preneoplastic event in breast cancer: A preliminary study. Oncol Lett. 2012; 3(2): 445-449. doi:10.3892/ol.2011.484.
8. Tate JG, Bamford S, Jubb HC, et al. COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res. 2019; 47(D1):D941-D947. doi:10.1093/nar/gky1015.
9. Nedeljkovic I, Lahousse L, Carnero-Montoro E, et al. COPD GWAS variant at 19q13.2 in relation with DNA methylation and gene expression. Hum Mol Genet. 2018; 27(2): 396-405. doi:10.1093/hmg/ddx390.